Panbela Therapeutics Inc at LD Micro Main Event XVI Conference Transcript
Okay, I'm excited to bring to you our next presentation. So please give a warm welcome to CEO, Dr. Jennifer Simpson of Panbela Therapeutics.
Thank you. Good afternoon, everyone. This presentation will contain forward-looking statements, so I do encourage you to look at the documents filed with the SEC.
So Panbela Therapeutics is a company that focuses on polyamines, and polyamines are key regulators of normal biology, and they are altered in many disease states. We have a combined pipeline that spans from preclinical through Phase III registration programs, which translates to approximately a $5 billion aggregate market potential across the lead indications. We have strategic synergies and partnerships, which help to fund many of the programs.
The management team is highly experienced. We have over 10 FDA approvals under our belt and decades of pharma experience, and this really positions the company well as we continue to execute on our clinical development
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
